
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development—A Systematic Review
Marcin Goławski, Piotr Lewandowski, Iwona Jabłońska, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 991-991
Open Access | Times Cited: 14
Marcin Goławski, Piotr Lewandowski, Iwona Jabłońska, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 991-991
Open Access | Times Cited: 14
Showing 14 citing articles:
Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
Kexin Yan, Troy Dumenil, Tang Bing, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 30
Kexin Yan, Troy Dumenil, Tang Bing, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 30
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
Ursino Pacheco-García, Jeanet Serafín‐López
Vaccines (2023) Vol. 11, Iss. 3, pp. 655-655
Open Access | Times Cited: 6
Ursino Pacheco-García, Jeanet Serafín‐López
Vaccines (2023) Vol. 11, Iss. 3, pp. 655-655
Open Access | Times Cited: 6
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals
Anna Offersgaard, Carlos R. Duarte Hernandez, Yuyong Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Anna Offersgaard, Carlos R. Duarte Hernandez, Yuyong Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
NANOTECHNOLOGY AND ITS PROSPECTIVE ROLE IN USING BIOACTIVE COMPOUNDS TO FIGHT COVID 19 INFECTION IN THIS ERA
Naglaa Hamdy, Essam El Sayed, Sahar Allm, et al.
Egyptian Journal of Desert Research (2023) Vol. 73, Iss. 2, pp. 513-549
Open Access | Times Cited: 3
Naglaa Hamdy, Essam El Sayed, Sahar Allm, et al.
Egyptian Journal of Desert Research (2023) Vol. 73, Iss. 2, pp. 513-549
Open Access | Times Cited: 3
Live attenuated COVID-19 vaccines: approaches to development and prospects for clinical use
E. R. Korchevaya, A. V. Gracheva, I. N. Dyakov, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 3, pp. 225-236
Open Access | Times Cited: 2
E. R. Korchevaya, A. V. Gracheva, I. N. Dyakov, et al.
Journal of microbiology epidemiology immunobiology (2023) Vol. 100, Iss. 3, pp. 225-236
Open Access | Times Cited: 2
Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Vaccine (2022) Vol. 41, Iss. 4, pp. 892-902
Open Access | Times Cited: 4
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Vaccine (2022) Vol. 41, Iss. 4, pp. 892-902
Open Access | Times Cited: 4
Review: Unravelling the Role of DNA Sensing in Alum Adjuvant Activity
Zara Gatt, Utku Gunes, Arianna Raponi, et al.
Discovery Immunology (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Zara Gatt, Utku Gunes, Arianna Raponi, et al.
Discovery Immunology (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Journal of microbiology epidemiology immunobiology (2024) Vol. 101, Iss. 1, pp. 36-51
Open Access
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Journal of microbiology epidemiology immunobiology (2024) Vol. 101, Iss. 1, pp. 36-51
Open Access
Development of an attenuated potato virus Y mutant carrying multiple mutations in helper-component protease for cross-protection
Xiaojie Xu, Xujie Sun, Chunju Liu, et al.
Virus Research (2024) Vol. 344, pp. 199369-199369
Open Access
Xiaojie Xu, Xujie Sun, Chunju Liu, et al.
Virus Research (2024) Vol. 344, pp. 199369-199369
Open Access
Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human
Daniel Chang He, Cheng-Qiang He
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Daniel Chang He, Cheng-Qiang He
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 3
State of the Globe: Navigating the Impact of SARS-CoV-2 Mutations on COVID-19 Testing
Rohit Varshney
Journal of Global Infectious Diseases (2023) Vol. 15, Iss. 2, pp. 41-42
Open Access | Times Cited: 1
Rohit Varshney
Journal of Global Infectious Diseases (2023) Vol. 15, Iss. 2, pp. 41-42
Open Access | Times Cited: 1
Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron VOCs
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Е. Б. Файзулоев, A. V. Gracheva, E. R. Korchevaya, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human
Daniel Chang He, Cheng-Qiang He
Research Square (Research Square) (2022)
Open Access
Daniel Chang He, Cheng-Qiang He
Research Square (Research Square) (2022)
Open Access